Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03680079 · ClinicalTrials.gov registry record · NA

High Risk Youth With Poorly-controlled Diabetes

A NA study of Type 1 Diabetes Mellitus, sponsored by Washington University School of Medicine.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT03680079 is a NA study of Type 1 Diabetes Mellitus that has completed, run by Washington University School of Medicine. The registered enrollment target is 9 participants, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03680079, a NA study of Type 1 Diabetes Mellitus, has completed, sponsored by Washington University School of Medicine.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

This study aims to implement a group education curriculum integrated with social media participation to provide peer support and interactive education sessions with the goal of improving glycemic control in disadvantaged youth with poorly-controlled type 1 diabetes.

Conditions Studied

Interventions

  • OTHER Group education sessions

Study Locations (1)

Missouri

  • St. Louis Children's Hospital - St Louis

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2018-09-01
Est. Completion 2019-06-30
Phase NA

What the Registry Record Tells You About NCT03680079

The ClinicalTrials.gov registry entry for NCT03680079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 140-participant average among 105 other Type 1 Diabetes Mellitus trials with a reported enrollment target (94% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Type 1 Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Group education sessions is the first listed.

NCT03680079 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03680079 about?

NCT03680079 is a clinical study titled "High Risk Youth With Poorly-controlled Diabetes". This study aims to implement a group education curriculum integrated with social media participation to provide peer support and interactive education sessions with the goal of improving glycemic control in disadvantaged youth with poorly-controlled type 1 diabetes.

What is the current status of trial NCT03680079?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2018-09-01. Estimated completion is 2019-06-30.

What conditions does trial NCT03680079 study?

This clinical trial studies the following conditions: Type 1 Diabetes Mellitus.

What interventions are being tested in trial NCT03680079?

The interventions under investigation include: Group education sessions (OTHER).

Who is sponsoring clinical trial NCT03680079?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03680079 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 1 Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.